Volume 46 - Article 31 | Pages 905–918
The contribution of smoking-attributable mortality to differences in mortality and life expectancy among US African-American and white adults, 2000–2019
Date received: | 29 Jul 2021 |
Date published: | 12 May 2022 |
Word count: | 2472 |
Keywords: | African Americans, disparities, life expectancy, mortality, smoking |
DOI: | 10.4054/DemRes.2022.46.31 |
Additional files: | Supplementary Material - Data and Calculations (Excel file, 199 kB) |
Supplementary Material - Life Tables (Excel file, 247 kB) | |
Abstract
Background: The role of smoking in racial disparities in mortality and life expectancy in the United States has been examined previously, but up-to-date estimates are generally unavailable, even though smoking prevalence has declined in recent decades.
Objective: We estimate the contribution of smoking-attributable mortality to observed differences in mortality and life expectancy for US African-American and white adults from 2000–2019.
Methods: The indirect Preston–Glei–Wilmoth method was used with national vital statistics and population data and nationally representative never-smoker lung cancer death rates to estimate the smoking-attributable fraction (SAF) of deaths in the United States by sex-race group from 2000–2019. Mortality rates without smoking-attributable mortality were used to estimate life expectancy at age 50 (e_50) by group during the period.
Results: African-American men had the highest estimated SAF during the period, beginning at 26.4% (95% CI:25.0%–27.8%) in 2000 and ending at 12.1% (95% CI:11.4%–12.8%) in 2019. The proportion of the difference in e_50 for white and African-American men that was due to smoking decreased from 27.7% to 14.8%. For African-American and white women, the estimated differences in e_50 without smoking-attributable mortality were similar to observed differences.
Conclusions: Smoking continues to contribute to racial disparities in mortality and life expectancy among men in the United States.
Contribution: We present updated estimates of the contribution of smoking to mortality differences in the United States using nationally representative data sources.
Author's Affiliation
Brian L. Rostron - US Food and Drug Administration, United States of America
Cindy M. Chang - US Food and Drug Administration, United States of America
Brittny C. Davis Lynn - US Food and Drug Administration, United States of America
Chunfeng Ren - US Food and Drug Administration, United States of America
Esther Salazar - US Food and Drug Administration, United States of America
Bridget K. Ambrose - US Food and Drug Administration, United States of America
Other articles by the same author/authors in Demographic Research
»
A modified new method for estimating smoking-attributable mortality in high-income countries
Volume 23 - Article 14
Most recent similar articles in Demographic Research
»
Life expectancy loss among Native Americans during the COVID-19 pandemic
Volume 47 - Article 9 | Keywords: disparities, life expectancy, mortality
»
Contribution of smoking-attributable mortality to life-expectancy differences by marital status among Finnish men and women, 1971-2010
Volume 36 - Article 8 | Keywords: life expectancy, mortality, smoking
»
A modified new method for estimating smoking-attributable mortality in high-income countries
Volume 23 - Article 14 | Keywords: life expectancy, mortality, smoking
»
Differential impact of the COVID-19 pandemic on excess mortality and life expectancy loss within the Hispanic population
Volume 48 - Article 12 | Keywords: disparities, life expectancy
»
Mexican mortality 1990‒2016: Comparison of unadjusted and adjusted estimates
Volume 44 - Article 30 | Keywords: life expectancy, mortality
Articles
Citations
Cited References: 26
»View the references of this article
Download to Citation Manager
Similar Articles
PubMed
»Articles by Brittny C. Davis Lynn
»Articles by Bridget K. Ambrose
Google Scholar
»Articles by Brittny C. Davis Lynn
»Articles by Bridget K. Ambrose